Side-by-side comparison
RHHVF vs SNY — Side-by-side comparison
Neither screens cheaper on EV/FCF, Neither has the higher ROIC, Neither has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.
RHHVF
Roche Holdings AG DIV RT
Price
$425.05
Market cap
$263.8B
Day %
N/A
SNY
Sanofi Aventis
Price
$44.29
Market cap
$133.3B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
RHHVF implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
SNY implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for RHHVF.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for SNY.
Grade F
0
/ 100
Quality Radar0 – 20 per axis